金双歧联合思密达治疗肝源性腹泻33例(英文)

【英文篇名】	golden bifid combined with smecta in treatment of the hepatogenous diarrhea:a report of 33 cases
【下载频次】湘西自治州人民医院传染科瞿章书	☆
【作者】	瞿章书; 汤丽娟; 张炜; 徐小平;
【英文作者】	qu zhang-shu tang li-jian zhang wei xu xiao-ping （department of infectious diseases; the people's hospital of xiangxi autonomous prefecture （first affiliated hospital of jishou university）; jishou; hunan province; china; 416000）;
【作者单位】	湖南省湘西自治州人民医院（吉首大学第一附属医院）传染科; 416000;
【文献出处】	现代生物医学进展 , progress in modern biomedicine, 编辑部邮箱 2007年 02期   期刊荣誉：aspt来源刊  cjfd收录刊
【中文关键词】	金双歧; 思密达; 肝源性腹泻;
【英文关键词】	golden bifid; smecta; hepatogenous diarrhea;
【摘要】	目的:研究金双歧联合思密达治疗肝源性腹泻的疗效。方法:将66例肝源性腹泻的病人分为两组,治疗组及对照组各33例。两组均给予适当休息、合理饮食,积极护肝及对症支持等综合治疗;在此基础上,治疗组使用金双歧(2．0g,每日三次)联合思密达(3．0g,每日三次)治疗;对照组口服左氧氟沙星(0．2g,每日两次)治疗。疗程均为7天～14天。疗效判断标准:①显效:腹泻消失,大便成形,每日一次;②有效:腹泻次数明显减少或大便基本成形;③无效:症状无改善或大便次数增多。以显效和有效计算总有效率。结果:治疗组显效13例,有效17例,总有效率90．9%;对照组显效10例,有效6例,总有效率48．5%。两组疗效对比差异有统计学意义(x2=15．45,p＜0．001)。结论:金双歧联合思密达治疗肝源性腹泻疗效显著,值得临床推广应用。
【英文摘要】	objective:to explore the therapeutic effect of golden bifid combined with smecta for the patients with hepatogenous diarrhea (hd).methods:66 patients with hd were randomly divided into treatment group (n=33) and control group (n=33).on the basis of protecting the liver and the complex treatment,the treatment group was given golden bifid (2.0g, three times a day) combined with smecta (3.0g,three times a day),and the control group was given levofloxacin (0.2g,twice a day).the efficacy standards were as follow...
【doi】	cnki:sun:swcx.0.2007-02-030
【更新日期】	2007-04-29
【分类号】	r575;r574.62
【正文快照】	the elinieal eharaeteristies and prognosis ofliverdiseasewas of importanee when the eoneept of hepatogenous diarrhea was proposed.we have adopted golden bifid(2.09，three times a day) eombined with smeeta(3.09，three times a day)in the treatment of33 ease